Cochlear Americas13059 East Peakview Avenuecentennial Co 80111 Pma Numberp970051 Supplement Numbers210 Date Received02 08 2022 Decision Date03 11 2022 Product Code Mcm Advisory Committee Ear Nose Throat Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Cochlear Americas13059 East Peakview Avenuecentennial Co 80111 Pma Numberp970051 Supplement Numbers210 Date Received02 08 2022 Decision Date03 11 2022 Product Code Mcm Advisory Committee Ear Nose Throat Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P970051S210 Cochlear Americas13059 East Peakview Avenuecentennial, CO 80111 PMA NumberP970051 Supplement NumberS210 Date Received02/08/2022 Decision Date03/11/2022 Product Code MCM  Advisory Committee Ear Nose & Throat Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	Nucleus 24 Cochlear Implant System	2022-03-11